| Identification | Back Directory | [Name]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine | [CAS]
1612191-98-6 | [Synonyms]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine
9-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine
9H-?Purine, 9-?(3-?deoxy-?3-?fluoro-?β-?D-?ribofuranosyl)?-?6-?[6-?(4-?morpholinyl)?-?3-?pyridinyl]?- | [Molecular Formula]
C19H21FN6O4 | [MDL Number]
MFCD29915406 | [MOL File]
1612191-98-6.mol | [Molecular Weight]
416.41 |
| Hazard Information | Back Directory | [Uses]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|